| Literature DB >> 34305863 |
Rob Van Houdt1, Joachim Vandecraen1,2, Wietse Heylen1, Natalie Leys1, Pieter Monsieurs1, Ann Provoost1, Abram Aertsen2.
Abstract
Cupriavidus metallidurans strains display a decreased viability when incubated in rich medium at a temperature of 37°C compared to their normal growth temperature of 30°C, a phenomenon coined "temperature-induced mortality and mutagenesis" (TIMM). To scrutinize this aberrant phenotype further, the contributions of specific inducers and protective agents were determined. Different growth media, including lysogeny broth (LB) and Schatz, and components, including casamino acids, in particular amino acids (proline, cysteine, glycine, glutamine, leucine, histidine and phenylalanine) and ammonium, were found to induce TIMM at 37°C. Sorbitol was found to counteract TIMM. Furthermore, although TIMM is well conserved within the C. metallidurans species, multiple and strain-specific TIMM inducers exist. Twenty-nine percent of the TIMM survivors inherited resistance to TIMM. Whole-genome sequencing of two resistant derivatives revealed an important role of an uncharacterized oxidoreductase, indicating putative metabolic poisoning when grown in high-concentration nitrogen-containing media at 37°C.Entities:
Keywords: Cupriavidus; amino acids; growth temperature; nitrogen; osmotic pressure
Year: 2021 PMID: 34305863 PMCID: PMC8299993 DOI: 10.3389/fmicb.2021.698330
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains and plasmids used in this study.
| CH34 | pMOL28, pMOL30, TIMM | |
| CH34-TIMM | CA TIMM | This study |
| CH34-TIMM | CA TIMM | This study |
| CH34-Km | CH34 harboring a EZ-Tn5 < | This study |
| CH34 Δ1009 | CH34 Rmet_1009:: | This study |
| CH34-TIMM | CH34-TIMM | This study |
| CH34-TIMM | CH34-TIMM | This study |
| DG1 | Strain for cloning and plasmid preparation | Eurogentec, B |
| MFD | MG1655 RP4-2-Tc::[Δ | |
| pACYC184 | p15A ori, Cm | Lab collection |
| pK18mob | pMB1 ori, Mob+, | |
| pK18mob-1009:: | This study | |
Survival frequency and isolation site/place of the different C. metallidurans strains used in this study as determined by the ratio of viable count on LB agar at 37 to 30°C.
| CH34 | 3.82 ± 0.52 × 10–5 | Decantation tank, zinc factory (BE) | |
| AE104 | 1.87 ± 0.31 × 10–5 | CH34 cured from pMOL28 and pMOL30 | |
| AE126 | 1.68 ± 0.34 × 10–4 | CH34 cured from pMOL30 | |
| AE128 | 1.69 ± 0.26 × 10–4 | CH34 cured from pMOL28 | |
| KT01 | 3.38 ± 0.46 × 10–5 | Wastewater treatment plant (DE) | |
| KT02 | 2.14 ± 0.22 × 10–5 | Wastewater treatment plant (DE) | |
| KT21 | 2.15 ± 0.18 × 10–5 | Wastewater treatment plant (DE) | |
| CH42 | 4.38 ± 0.46 × 10–5 | Polluted sediments, zinc factory (BE) | |
| CH79 | 3.18 ± 0.37 × 10–6 | Polluted sediments, zinc factory (BE) | |
| AS39 | 6.85 ± 0.56 × 10–5 | Mine tailings (CG) | |
| AS167 | 2.63 ± 0.24 × 10–4 | Mine tailings (CG) | |
| AS168 | 1.05 ± 0.12 × 10–4 | Mine tailings (CG) | |
| 31A | 5.07 ± 0.82 × 10–5 | Galvanization tank, metal factory (DE) | |
| SV661 | 1.13 ± 0.21 × 10–4 | Non-ferrous industry (BE) | |
| ccug38404 | 1.85 ± 0.32 × 10–4 | Human urine | CCUG1 |
| ccug43015 | 1.96 ± 0.46 × 10–4 | Human cerebrospinal fluid | CCUG |
| ccug45957 | 1.73 ± 0.24 × 10–4 | Pharmaceutical industry (SE) | CCUG |
| H1130 | 4.76 ± 0.36 × 10–5 | Clinical Isolate | |
| NE12 | 4.03 ± 0.28 × 10–5 | Cleanroom Kennedy Space Center (United States) | |
| NA1 | 9.5 0 ± 0.54 × 10–3 | Water storage system (ISS) | |
| NA2 | 8.70 ± 0.41 × 10–3 | Contingency water container (ISS) | |
| NA4 | 2.61 ± 0.23 × 10–4 | Water recovery system (ISS) |
FIGURE 1Tenfold serial dilution of a stationary phase culture of CH34 spotted on LB agar plates and incubated at 37°C (upper row) for 0, 24, 48, 72 and 96 h before shifting to an 48 h incubation period at 30°C (lower row).
Different media and strains used in this study to evaluate TIMM induction (+ for induction and − for no induction) as determined by the ratio of viable count at 37 to 30°C.
| LB (1% NaCl, 0.5% YE, 1% P)1 | + | + |
| 0.5% YE + 1% NaCl | + | + |
| 1% P + 1% NaCl | + | − |
| MM284 (0.5% NaCl, 0.2% NH4Cl) | − | − |
| MM284 + 0.5% CA2 | + | − |
| MM284 + 0.5% Phe | + | − |
| MM284 + 0.5% Gly | + | − |
| MM284 + 0.5% Cys | + | − |
| MM284 + 0.5% Leu | + | − |
| MM284 + 0.5% Pro | + | − |
| MM284 + 0.5% Gln | + | − |
| MM284 + 0.5% His | + | − |
| MM284 − NaCl | + | − |
| MM284 + 0.5% NH4Cl | − | − |
| MM284 + 1% NH4Cl | + | − |
| MM284 + 0.5% NH4NO3 | − | − |
| MM284 + 1% NH4NO3 | + | − |
| MM284 + 1% NaCl | − | − |
| Schatz (0.1% NH4NO3) | + | + |
| Schatz + 1% NaCl | − | − |
| Schatz + 1% NaCl + 0.5% CA | + | − |
| +0.44 M sorbitol3 | − | − |
Effect of supplementing a specific amino acid to MM284 at a final concentration of 0.5% (w/v) on TIMM induction for different C. metallidurans strains (+ for induction and − for no induction) as determined by the ratio of viable count at 37 to 30°C.
| – | − | − | − | − | − |
| Ala | − | − | − | − | − |
| Gly | − | + | + | + | − |
| Ile | − | − | − | − | − |
| Leu | − | − | − | + | − |
| Met | − | − | − | − | − |
| Pro | + | + | − | + | − |
| Val | − | − | − | − | − |
| Asn | − | − | − | − | − |
| Cys | + | + | + | − | + |
| Gln | + | + | + | − | − |
| Ser | − | − | − | − | − |
| Thre | − | − | − | − | − |
| Arg | − | − | − | − | − |
| Asp | − | − | − | − | − |
| Glu | − | − | − | − | − |
| His | + | − | − | + | − |
| Lys | − | − | − | − | − |
| Phe | + | + | + | + | + |
| Trp | − | − | − | − | − |
| Tyr1 | ND* | ND* | ND* | ND* | ND* |
FIGURE 2Characterization of TIMM survivors. (A) Inherited resistance of 100 TIMM survivors, originally isolated on MM284 containing 0.5% (w/v) L-phenylalanine, to different TIMM-promoting conditions as determined by the ratio of viable count at 37 to 30°C. Phe: L-phenylalanine, CA: casamino acids. (B) Relative fitness of the parental strain CH34 (red), CH34-TIMM (blue) and CH34-TIMM (green) in MM284 at 30°C, as determined by the ratio of viable count of the strains to CH34-Km in function of time.
Identified mutations in CH34-TIMM (R1) and CH34-TIMM (R2).
| CHR1 | Hydrogenotrophy | Δ 60 kb | + | + | |
| CHR1 | 0862 | Conserved hypothetical protein | INS IS | + | − |
| CHR1 | 1009 | Oxidoreductase/nitroreductase | SNP | + | + |
| CHR1 | 1107 | Putative membrane protein | INS IS | + | − |
| CHR1 | 1492 | Fructose-bisphosphate aldolase | 2 SNPs | + | − |
| CHR1 | 1563 | Transposase IS | 2 SNPs | + | − |
| CHR1 | 1885 | Proteolytic subunit of ClpA-ClpP and ClpX-ClpP ATP-dependent serine proteases | SNP | − | + |
| CHR1 | 1886 | Peptidyl-prolyl | INS IS | − | + |
| CHR1 | 2409 | Phosphatidylglyc erophosphate synthetase | INS IS | + | − |
| CHR1 | 6452 | Hypothetical protein | 2 SNPs | − | + |
| CHR2 | 3658 | Type II secretion system protein | SNP | − | + |
| CHR2 | 4106 | Acetone carboxylase α-subunit | SNP | + | − |
| CHR2 | 4757 | Hypothetical protein | INS Tn | − | + |
| CHR2 | 4970 | Formyl-CoA transferase | SNP | − | + |
| CHR2 | 4972 | Tn | Δ 6 kb | − | + |
| CHR2 | 5469 | Hypothetical protein | INS IS | + | − |
| CHR2 | 5806 | Ferric citrate outer membrane transporter | INS IS | + | − |
| pMOL28 | 6321 | Conserved hypothetical protein | +1 frameshift | + | + |
| pMOL28 | 6326 | Conserved hypothetical protein | INS IS | + | − |
| pMOL30 | 6072 | Putative transcriptional regulator | SNPs | + | − |
| pMOL30 | 6072 | Putative transcriptional regulator | INS IS | + | − |
| pMOL30 | 6097 | 2-Nitropropane dioxygenase | SNP | − | + |
FIGURE 3Tenfold serial dilution of stationary-phase cultures of CH34, CH34-TIMM and CH34-TIMM, and their Rmet_1009 insertional knockout mutants spotted on MM284 agar plates with and without 0.5% (w/v) CA and incubated for 2 days at 30 and 37°C.